Canada Markets closed

AMRN Jan 2024 1.000 put

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
0.3000-0.2000 (-40.00%)
As of 09:32AM EST. Market open.
Full screen
Previous Close0.5000
Open0.3000
Bid0.2500
Ask0.4000
Strike1.00
Expire Date2024-01-19
Day's Range0.3000 - 0.3000
Contract RangeN/A
Volume1
Open Interest150
  • GlobeNewswire

    Amarin Announces VAZKEPA® (Icosapent Ethyl) Approved By Medsafe In New Zealand

    Marks 7th Regulatory Approval for VASCEPA®/VAZKEPA® Franchise in Key International Markets Since 2022DUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 27, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that Medsafe in New Zealand has granted approval to VAZKEPA (icosapent ethyl) to reduce the risk of cardiovascular (CV) events in adult statin-treated patients with high CV risk with elevated triglycerides. Cardiovascular disease is a significant health issue for people li

  • GlobeNewswire

    Amarin to Present at SVB Securities Global Biopharma Conference

    DUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 27, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that Karim Mikhail, Amarin’s president and chief executive officer, is scheduled to participate at the SVB Securities Global Biopharma Conference. SVB Securities Global Biopharma Conference (February 13-16th, 2023; Virtual) Date/Time: February 14, 2023 10:40 a.m. ET Webcast: https://wsw.com/webcast/svb8/register.aspx?conf=svb8&page=amrn&url=https://wsw.com/webcast/svb8/am

  • Zacks

    Amarin Corporation (AMRN) Down 13% in One Week: Here's Why

    Shares of Amarin Corporation (AMRN) fell last week as the company's largest shareholder pressurizes the company to make changes to its board of directors.